Chardan Capital Decreases Earnings Estimates for Prothena
Prothena Co. plc (NASDAQ:PRTA – Free Report) – Stock analysts at Chardan Capital decreased their FY2025 earnings per share (EPS) estimates for shares of Prothena in a research note issued on Tuesday, May 27th. Chardan Capital analyst R. Li now anticipates that the biotechnology company will post earnings per share of ($3.80) for the year, […]
Prothena Co. plc (NASDAQ:PRTA – Free Report) – Stock analysts at Chardan Capital decreased their FY2025 earnings per share (EPS) estimates for shares of Prothena in a research note issued on Tuesday, May 27th. Chardan Capital analyst R. Li now anticipates that the biotechnology company will post earnings per share of ($3.80) for the year, […]
